 double-blind placebo-control trial buflomedil treatment raynaud phenomenon six-month follow-up efficaci buflomedil mean daili frequenc sever winter ischem attack random double-blind placebo-control trial patient buflomedil group placebo group idiopath raynaud phenomenon month efficaci nail fold capillaroscopi signific allevi hemodyman disturb background pallor comparison placebo result term clinic laboratori safeti paramet six-month period satisfactori possibl long-term treatment